The key takeaways for this program are:
- Understanding the Prometheus decision and what the Supreme Court did and did not say;
- Understanding the question at issue in Myriad and how it is similar—and different—from that decided in Prometheus;
- Learning possible patent claim strategies to protect personalized medicine methods and biotechnology inventions under the new paradigm;
- Reviewing the U.S. Patent Office Guidance to Examiners, issued shortly after the Supreme Court decided Prometheus; and
- Discussing Options for strengthening already granted patents.
People
Related Insights
18 April 2024
Events
2024 Global Cyber Security Initiative (GCSI 2024) 5th Annual Conference
Foley partner Aaron Tantleff, a member of the firm’s Technology Transactions, Cybersecurity, and Privacy Practice, is participating as one of two distinguished keynote speakers at the GCSI 5th Annual Conference in Chicago on April 18.
17 April 2024
Manufacturing Industry Advisor
International Compliance and Risk-Mitigation Heat Map (2024 Update)
These interactive international compliance and risk-mitigation heat maps present quick visual indications of relative bribery, sanctions, and human rights compliance risks in every country around the globe.
23 April 2024
Events
HIN Chicago Debut: Greek Startups and the Greek Entrepreneurial Ecosystem
Join us for HIN's Chicago debut with an evening of networking and inspiration as Jimmy Samartzis, CEO of LanzaJet, tells us about his journey, the state of the CleanTech industry, and opportunities for entrepreneurs.